Healthtech funding in Q3 2017
European Healthtech startup funding raised during Q3 2017.
In Q3 2017, 110 European Healthtech companies closed 112 funding rounds and raised €1.5B in equity funding (excluding debt and grants), up 280.3% versus Q3 2016. Switzerland led by capital raised, and Seventure Partners was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.5B
+280.3% vs Q3 2016 · excl. debt & grants
Funding rounds
112
+53.4% vs Q3 2016
Companies
110
Top country
Switzerland
Rank among sectors
#1
15.2% of sector funding
Top-10 round share
76.2%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q3 2017 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €237M | 47 |
| Aug | €1.1B | 29 |
| Sep | €207M | 36 |
Top countries
by € raisedHealthtech — top countries by capital, Q3 2017 — interactive chart.
Data table
| Healthtech — top countries by capital, Q3 2017 | |
|---|---|
| Switzerland | €1.0B |
| France | €214M |
| UK | €125M |
| Israel | €76M |
| Germany | €17M |
| Finland | €15M |
| Ireland | €15M |
| Sweden | €15M |
Stage mix
by € raisedHealthtech — stage mix, Q3 2017 — interactive chart.
Data table
| Healthtech — stage mix, Q3 2017 | |
|---|---|
| Growth/Late | €938M |
| Other | €263M |
| Series A | €121M |
| Series B | €63M |
| Series C | €50M |
| Series D+ | €37M |
| Seed | €20M |
| Early VC | €4.2M |
| Grant | €1.6M |
Top deals
largest disclosed rounds in Q3 2017| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Growth/Late | Aug 2017 | €938M |
| Nightstar | Series C | Jul 2017 | €39M |
| Sophia Genetics | Series D+ | Jul 2017 | €26M |
| NicOx | Other | Sep 2017 | €26M |
| GenSight Biologics | Other | Sep 2017 | €23M |
| Push Doctor | Series B | Aug 2017 | €22M |
| Ieso | Other | Sep 2017 | €20M |
| Eligo Bioscience | Series A | Sep 2017 | €17M |
| Sparingvision | Other | Jul 2017 | €16M |
| Bioserenity | Series A | Aug 2017 | €15M |
| Kuros | Other | Sep 2017 | €15M |
| Simba Sleep | Other | Sep 2017 | €15M |
| Blueprint Genetics | Series A | Aug 2017 | €14M |
| Diabeloop | Other | Sep 2017 | €14M |
| Magenta Medical | Series B | Aug 2017 | €13M |
Top investors
most active in Q3 2017, by deal count- Seventure Partners5 deals
- High-Tech Gründerfonds (HTGF)4 deals
- IDInvest Partners4 deals
- Bpifrance3 deals
- Accelerated Digital Ventures2 deals
- Atlantic Labs2 deals
- Draper Esprit2 deals
- Gefen Capital2 deals
- IBB Beteiligungsgesellschaft2 deals
- Jørgen Lindskov Knudsen2 deals